SCHEMBL4915036

SCHEMBL4915036

O=C(NCc1ccc(C(=O)NO)cc1)Nc1cc2ccccc2cc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 14/20 0.61
HDAC1 Q13547 13/20 0.61
HDAC8 Q9BY41 6/20 0.61
HDAC11 Q96DB2 5/20 0.61
HDAC2 Q92769 5/20 0.61
HDAC3 O15379 4/20 0.61
HDAC4 P56524 4/20 0.61
HDAC7 Q8WUI4 4/20 0.61
HDAC10 Q969S8 4/20 0.61
HDAC9 Q9UKV0 4/20 0.61
HDAC5 Q9UQL6 4/20 0.61
KDM4E B2RXH2 2/20 0.48
GSK3B P49841 1/20 0.48
KDM1A O60341 2/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5595023 0.85 KDM4E (0.64) KDM4EGSK3BCA12CA1CA2
SCHEMBL4921268 0.84 HDAC6 (0.69) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL4930733 0.78 HDAC6 (0.67) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL4921364 0.78 HDAC1 (0.67) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL14260700 0.77 HDAC1 (0.80) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL6919516 0.76 HDAC6 (0.81) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL4930695 0.76 HDAC6 (0.53) HDAC6HDAC1HDAC11CA2MEN1
SCHEMBL10207296 0.76 HDAC6 (1.00) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL4925834 0.76 HDAC6 (0.58) HDAC6HDAC1HDAC8HDAC11HDAC2
SCHEMBL15289681 0.75 HDAC1 (1.00) HDAC6HDAC1HDAC8HDAC11HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2008-10-30 US disclosed
CN-101087601-A Compounds for inhibiting copper-containing amine oxidases and uses thereof GENMEDICA THERAPEUTICS SL (ES) 2007-12-12 CN disclosed
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof GENMEDICA THERAPEUTICS SL (ES) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269282-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HDAC6 2092/4885HDAC1 563/4885HDAC8 3399/4885
US-20070066646-A1 Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof AOC2, AOC3, AOC1 HDAC6 2060/4885HDAC1 622/4885HDAC8 3570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.